|
Office of Biotechnology Activities
|
National Institutes of Health - Office of Science Policy
|
| |
| RAC June 9, 2004 - Presentation Materials |
|
| 96th Meeting Day 2 |
| Bethesda, Maryland |
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
Discussion of Human Gene Transfer Protocol #0404-638 |
|
|
| |
Phase I Trial of Intramuscular Injection of a Recombinant Adeno-Associated Virus 1-Alpha 1-Antitrypsin (rAAV1-CB-hAAT) Gene Vector to AAT-Deficient Adults |
|
|
| |
Terence R. Flotte, M.D., University of Florida |
|
|
| |
Webcast
Slides
|
|
| |
|
|
|
|
Discussion of Human Gene Transfer Protocol #0404-643 |
|
|
| |
A Phase I/II Dose-Escalation Trial of Intravesical CG0070 for Superficial Transitional Cell Carcinoma of the Bladder after Bacillus Calmette-Guerin Failure |
|
|
| |
John Nemunaitis, M.D., US Oncology, Inc., Dallas, TX |
|
|
| |
Webcast
Slides
|
|
| |
|
|
|
ADJOURN |
|
| |
|
Top of Page |
| |
|
|
|
|
|
|